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Melanin-concentrating hormone (MCH) is a hypothalamic neuropeptide that promotes positive energy balance and anxiety. Since
dopamine (DA) is also closely implicated in these functions, the present study investigated the effect of DA on MCH neurons. Using
whole-cell patch-clamp recordings in rat brain slices, we found that DA hyperpolarizes MCH neurons by activating G-protein-activated
inwardly rectifying K (GIRK) channels. Pharmacological study indicated that the effect was mediated by 2A adrenoceptors, not DA
receptors. DA-induced outward current was also observed in the presence of tetrodotoxin or the dopamine -hydroxylase inhibitor
fusaric acid, suggesting thatDAdirectlybinds to2AreceptorsonMCHneurons, rather thanactingpresynapticallyorbeing transformed
into norepinephrine (NE) in the slice preparation. The effects of NE and DAwere concentration-dependent with EC50 of 5.9 and 23.7M,
respectively, and amaximal effect of 106.6 and 57.2 pA, respectively, suggesting that DA functions as a partial agonist. Prolonged (5min)
activation of2A receptors by eitherDAorNE attenuated the subsequent response toDAorNE,while 5 s applicationswere not sufficient
to induce desensitization. Therefore, a history of 2A receptor activation by DA or NE can have a lasting inhibitory effect on the
catecholaminergic transmission to MCH neurons. Our study suggests that 2A receptors expressed by MCH neurons may be one of the
pathways by which DA and NE can interact and modulate mood and energy homeostasis, and this cross talk may have functional
implications in mood disorders and obesity.
Introduction
Melanin-concentrating hormone (MCH) is an important regu-
latory peptide implicated in energy balance, reward, and mood.
MCHpromotes positive energy balance by increasing food intake
(Qu et al., 1996; Shimada et al., 1998; Ludwig et al., 2001) and
sleep (Verret et al., 2003; Willie et al., 2008), while inhibiting
metabolism and locomotion (Shimada et al., 1998; Marsh et al.,
2002). MCH also modulates behavioral responses to palatable
food and drugs of abuse by its action in the nucleus accumbens
(Borowsky et al., 2002; Smith et al., 2005; Chung et al., 2009).
Involvement of MCH in emotion and mood disorders has been
put forward by studies demonstrating that MCH receptor antag-
onists exert anxiolytic and antidepressant effects in animal mod-
els (Borowsky et al., 2002; Georgescu et al., 2005).
Dopamine (DA) and norepinephrine (NE) are classical neu-
rotransmitters with a significant overlap in the breadth of physi-
ological functions with MCH. Direct interactions between these
neurochemical systems are highly likely, since MCH is expressed
predominantly within in the lateral hypothalamus (LH), perifor-
nical area (PFA), and zona incerta (Bittencourt et al., 1992),
where significant NE and DA projections and DA cell bodies are
found (Leibowitz and Brown, 1980; Baldo et al., 2003; Sita et al.,
2003). Catecholamine signaling in the LH/PFA suppresses food
intake (Leibowitz and Brown, 1980; Adamson et al., 2010), which
entails the ascending projections from the brainstem (Leibowitz
and Brown, 1980). It is also well established that NE and DA are
involved in wakefulness, reward, and mood (Saper et al., 2005;
Nestler and Carlezon, Jr., 2006; Itoi and Sugimoto, 2010).
At the cellular level, NE has been shown to directly hyperpo-
larize MCH neurons through 2 adrenoreceptors (2Rs) and
Ba2-sensitive G-protein-activated inwardly rectifying K
(GIRK) channels (Gao et al., 2003; van den Pol et al., 2004).
However, the effect of DA on MCH neurons has yet to be dem-
onstrated. The present study provides evidence showing that DA
inhibitsMCHneurons by activating2A adrenoceptors (2ARs)
rather than their cognate receptors. Such cross talk between DA
and NE may be important for the regulation of the MCH system
and related functions.
Materials andMethods
All experiments were performed following the Canadian Council on
Animal Care guidelines and as approved by the Memorial University
Institutional Animal Care Committee. Sprague Dawley rats (60–70 g, 3-
to 4-weeks-old) were obtained from the breeding colony at Memorial
University. Males were used for all experiments except one, which used
females (see Results, below).
Under deep halothane anesthesia, brains were removed and 250-m-
thick coronal hypothalamic slices were generated in ice-cold buffer solu-
tion [containing the following (inmM): 87NaCl, 2.5 KCl, 1.25NaH2PO4,
7 MgCl2, 0.5 CaCl2, 25 NaHCO3, 25 glucose, 30 sucrose, 3 pyruvic acid,
and 1 ascorbic acid] or artificial CSF (ACSF) [containing the following
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(in mM): 126 NaCl, 2.5 KCl, 1.2 NaH2PO4, 1.2
MgCl2, 2 CaCl2, 18 NaHCO3, 10 glucose, 1
ascorbic acid]. Slices were incubated at 33–
34°C for 30–45min in ACSF and then at room
temperature until the recording. Solutions
were continuously bubbled with O2 (95%)/
CO2 (5%).
A hemisected slice was perfused in a record-
ing chamber at 1.5–2ml/min with ACSF at 33–
35°C. Whole-cell patch-clamp recording was
performed using a Multiclamp 700B amplifier
and pClamp 9.2 (Molecular Devices). Record-
ing electrodes were 3–9 M (majority, 3–6
M) when filled with an internal recording so-
lution containing the following (in mM): 123
K-gluconate, 2 MgCl2, 8 KCl, 0.2 EGTA, 10
HEPES, 4 Na2-ATP, 0.3 Na-GTP, pH 7.3, and
290–295 mOsmol. In some experiments,
K-gluconate was replaced with equimolar KCl.
Using an infrared-differential interference
contrastmicroscope (DMLFSA; LeicaMicrosys-
tems), neurons in the dorsal PFA, LH, or zona
incerta with a diameter of 10–20 m were se-
lected. Series resistance was 10–30M (average,
18.7 5.5M). To characterize the electrophys-
iological features and excitability of recorded
cells, a series of hyperpolarizing and depolarizing
300 ms step pulses were injected in current-
clampmode (200 to100 pA in 100 pA incre-
ments). Resting input resistance was calculated
from the steady-state voltage response to
100 pA current pulse. MCH neurons were
characterized by spike adaptation upon positive
current injection and the absence of spontaneous
firing, Ih, and rebound depolarization upon neg-
ative current offset (Alberto et al., 2006) (Fig.
1B); only cells that displayed all of these electro-
physiological characteristics were used for analy-
sis. Upon recording, a subset of cells was labeled
by including biocytin (1–1.5mg/ml) in the inter-
nal solution.Fifty-six cellsdisplaying these typical
characteristicswere successfully labeled and 46 of
these (82.1%) were determined to be MCH-
immunopositive, suggesting that MCH neurons
are identifiable by electrophysiological character-
istics. Ten remaining cells were neither MCH-
nor orexin-immunopositive, some of which
could be accounted for by technical issues associ-
ated with staining of thick sections.
Voltage-clamp experiments used a holding
potential of70mV, except in a subset of cells
where voltage ramps (140 to 20 mV in
0.6 s) were applied. Membrane currents were
filtered at 1 kHz, digitized at 5 and 1 kHz, and
stored for off-line analysis. Hyperpolarizing
pulses (20 mV, 100 ms) were applied every
20–60 s to monitor input and series/access
resistance.
Data are expressed as mean  SEM. Stu-
dent’s t test (unpaired and paired) and one-
way ANOVA with Dunnett’s posttest were
used for statistical comparisons. p  0.05 was
considered significant. Regression lines, EC50, maximal drug response,
and half-recovery time were calculated using GraphPad Prism 4.
All drugswere bath perfused or locally applied byValveBank perfusion
system (Automate Scientific) (for concentrations, see Results, below) by
diluting aliquots of 1000 stock in the ACSF before use. Local applica-
tions were through a four-channel perfusion pencil with a tip diameter of
250mlocated close to the target neuron (100mfrom the soma).DA
stock included ascorbic acid (1 mM) and DA and NE solutions were
light-protected throughout the procedures to minimize oxidation.
Tertiapin-Q, LE300, sulpiride, SKF81297, quinpirole, yohimbin, and
BLR44408 were purchased from Tocris Bioscience. DA, NE, biocytin,
picrotoxin, DNQX, D-AP5, and fusaric acid were from Sigma-Aldrich
(St. Louis, MO); and tetrodotoxin was from Alomone Labs.
After recordings, some brain slices underwent immunohistochemical
verification as described previously (Alberto et al., 2006). Briefly, slices
Figure 1. Dopamine inhibits MCH neurons via GIRK channel activation. A, Representative experiment showing a DA-induced
reversible hyperpolarization. Vertical lines denote responses to negative and positive current injections.B, Same experiment as in
A, except traces fromthe timepoints indicated inAare expanded to showthedetailed characteristics ofMCHneurons, suchas a lack
of Ih, rebound depolarization, and spontaneous firing. DA hyperpolarizes MCH cell and abolishes action potentials. C, Changes in
restingmembrane potential induced by DA. Each dot represents a cell and horizontal lines indicate the average value. *p 0.05,
paired t test versus baseline. D, Representative voltage-clamp trace showing a DA-induced current. E, Left, Current–voltage
relationship in the presence and absence of DA. Inset, Voltage protocol used. Right, Subtracted trace showing the DA-induced
current. F, Tertiapin-Q (TQ) attenuates DA current. **p 0.01, unpaired t test. Numbers denote the numbers of cells tested.
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were fixed in 4% paraformaldehyde or 10% formalin overnight, then
incubatedwith anti-MCH rabbit IgG (1:2000; Phoenix Pharmaceuticals)
and anti-orexin A goat IgG (1:2000; Santa Cruz Biotechnology) for 3 d,
followed by appropriate secondary antibodies and streptavidin-conjugated
amino-methyl-coumarin-acetate (1:500). Slices were examined under a flu-
orescence microscope forMCH, orexin A immunoreactivity, and biocytin.
Results
To test the effect of DA on the excitability of MCH neurons, DA
(1–100M) was bath-applied while recording themembrane po-
tential in current-clampmode. In response toDA,MCHneurons
were reversibly hyperpolarized in a concentration-dependent
manner (Fig. 1A–C) with a concomitant decrease in input resis-
tance by 9.8 and 37.2% at 10 and 100 M, respectively, (10 M:
n  4, p  0.05; 100 M: n  3, p  0.05, paired t test) from a
baseline value of 431.0  39.7 M. In voltage clamp, DA (100
M) induced an outward current that was readily reversible upon
wash (Fig. 1D). This effect was observed in 100% of cells tested
regardless of the localization within the LH, PFA, and zona in-
certa. Similar DA currents were observed ( p 	 0.05, ANOVA)
with high KCl-containing pipette solution (n 11), in the pres-
ence of a Na channel blocker tetrodotoxin (1 M), glutamater-
gic receptor antagonists DNQX (10 M) and D-AP5 (10 M)
(n  12), and GABAA receptor channel blocker picrotoxin (50
M; n 4), suggesting that the inhibitory effect of DA on MCH
neurons is direct and independent of Cl. DA also induced an
outward current in MCH neurons from female rats (49.4  6.7
pA, n  11), which was not significantly different from those
frommales (43.4 3.8 pA, n 24, p	 0.05, unpaired t test). The
remainder of the study was performed on brain slices obtained
from male rats.
When a voltage ramp was applied to determine the effect of
DA over a wide range of membrane potentials, we found that the
DA-induced current reversed at 97.1  3.9 mV with some
inward rectification, indicative of a K current involvement (n
7) (Fig. 1E). Since DA receptors are G-protein coupled, we spec-
ulated that GIRK channels were the effector channels. Thus, we
tested the effect of tertiapin-Q (300 nM), a selectiveGIRK channel
blocker, which significantly attenuated the DA-induced outward
current (Fig. 1F).
We then sought to identify the receptor subtype thatmediated
the DA current. As shown in Figure 2A, neither the D1-like re-
ceptor antagonist LE300 [10 nM (Han and Whelan, 2009)] nor
D2-like receptor antagonist sulpiride [10 M (Alberto et al.,
2006)] individually or in combination inhibited the DA effect.
Moreover, amixtureofD1-andD2-like receptoragonists SKF81297
(10 M) and quinpirole (50 M), respectively, failed to induce an
outward current. Because DA is known to bind 2Rs in the brain
(Cornil and Ball, 2008) and activation of 2Rs has been shown to
hyperpolarize MCH neurons (van den Pol et al., 2004), we turned
our attention to2Rs.Yohimbin (5M), the2Rantagonist, almost
completely blocked the DA-induced current, suggesting that DA
does indeed activate these receptors in MCH neurons. There are
three 2R subtypes (2A, 2B, and 2C) and 2AR have been identi-
fied inMCHneurons (Modirrousta et al., 2005). Thus,we tested the
2AR-specific antagonistBLR44405 (3M)and found that it largely
inhibits the effect of DA (Fig. 2A). These receptors also mediate the
effect of NE (Fig. 2B).
While it seems reasonable to conclude that DAwas binding to
2ARs, another possible explanation for the apparent cross talk is
conversion of DA to NE within the slice, and subsequent binding
of NE to its cognate receptors. Thus, we used fusaric acid to
specifically block dopamine -hydroxylase, the enzyme respon-
sible for synthesizing NE from DA (Hidaka, 1971). It was found
that fusaric acid (100 M) pretreatment for 10 min had no effect
on DA-induced outward current (Fig. 2A), suggesting that DA
itself binds adrenoceptors to exert its effect. Concentration–re-
sponse curves revealed that NE and DA had an EC50 of 5.9 and
23.7M, respectively, and calculated maximal effect of 106.6 and
57.2 pA, respectively (Fig. 2C). Together, our data suggest that
DA activates GIRK channels in MCH neurons by directly inter-
acting with 2ARs as a partial agonist.
Agonist-dependent desensitization has been suggested as a
general characteristic of GIRK currents (Leaney et al., 2004).
Therefore, we tested the hypothesis that DA and NE cross-
desensitize each other through 2AR-mediated GIRK current
activation. DA or NE (both 100 M, which induces a robust re-
sponse) was applied for 3–5min, and was tested again after a 5 or
10 min wash. When NE was first applied, the subsequent DA
current was significantly smaller than that seen when DA was
applied for the first time onto the slice (Fig. 3A,E). A prior DA
challenge also attenuated the subsequent DA effect (Fig. 3B,E).
In contrast, NE still induced a current of considerable size follow-
ing a 5 min DA and 5 min wash, but it was50% of the current
Figure 2. Dopamine acts as a partial agonist of2A receptors. A, Summary of DA-induced
currents in the presence of DAor2 antagonist. DA effect is blockedby2 (yohimbin) and2A
antagonist (BLR44405), but not by DA antagonists (LE300 and/or sulpiride). Ineffectiveness of
D1- and D2-like agonists is also shown (SKF81297  quinpirole). DA effect persists in the
dopamine--hydroxylase inhibitor fusaric acid. **p 0.01 versus DA 100 M, ANOVA with
Dunnett’s posttest. ns, Not significant. B, NE response is also inhibited by BLR44408. ***p
0.0005, unpaired t test. C, Concentration–response curve for DA (n 3–8) andNE (n 5–6),
demonstrating that DA is a partial agonist. Numbers in bar graphs indicate cell numbers
included.
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induced by NE applied for the first time
(Fig. 3C,F). When NE was applied twice
(5 min each, 5 min interval), the second
NE current was also significantly desensi-
tized (Fig. 3D,F). To determine how long
it takes for the DA effect to recover from
desensitization, DA was applied twice for
5 min each with various intervals, and the
second response was normalized to the
first one to measure the degree of desen-
sitization. As shown in Figure 3G, DA
current recovered exponentially with
time, with a half-recovery time of 11.9
min (r 2  0.63).
In contrast to long-term bath applica-
tions (3–5min), brief local applications (5 s)
did not induce significant desensitization.
When DA was tested following a 5 s NE
and 5 min wash, DA still induced a cur-
rent equivalent to that induced by DA ap-
plied for the first time (Fig. 3H). Similarly,
NE current was not desensitized by prior
application of DA for 5 s (Fig. 3I). The
peak amplitude of DA or NE current was
consistent regardless of themode of appli-
cation (bath or local), suggesting that the
initial peak current was not desensitized
even when the compounds were being
bath applied (Fig. 3H, I). This result sug-
gests that significant receptor desensitiza-
tion occurs only when there is prolonged
ligand activity.
Discussion
The present study provides evidence that
DA directly inhibits MCH neurons by ac-
tivating 2ARs, but not DA receptors. NE
also acts on 2AR subtype to modulate
MCH neurons. However, a lack of effect by
fusaric acid, the dopamine -hydroxylase
inhibitor, suggests that activation of adren-
ergic receptors by DA was not due to con-
versionofDA toNE in the slice preparation,
but rather DA itself binding to the receptor.
Apparent lack of DA receptor involvement
is inagreementwithaprevious report show-
ing no expression of D1, D2, D3, D4, or D5
receptor mRNA in LH/PFA dorsal to the
fornix (Bubser et al., 2005), where MCH
neurons aremainlydistributed (Bittencourt
et al., 1992). DA has been shown to be a
functional ligand for2Rs in several neuro-
nal types (Aguayo andGrossie, 1994; Zhang
et al., 1999; Cornil et al., 2002) anddisplaces
2 ligand virtually everywhere in the brain
(Cornil and Ball, 2008). Nonetheless, to the
best of our knowledge, this is the first dem-
onstration that DA binds and acts as a partial agonist to endoge-
nously expressed 2A subtype in intact neurons. It is likely that DA
binds at least partially within the same catecholamine binding
pocket of 2AR as NE, since the radiolabeled 2 antagonist is dis-
placed from these receptors by both DA and NE in competition
binding assays (Zhang et al., 1999). According to a study that tested
the ability of various ligands to activate 2ARs by measuring the
agonist-induced stimulation of [35S]GTPS binding in isolated cell
membranes, NE ismuchmore efficient at activating2AR thanDA
(Nyro¨nen et al., 2001),whichmay explain the difference in themax-
imal effects induced byDAandNE in the present study.DA andNE
notonly share receptors but also the effector channels, namelyGIRK
Figure 3. Cross-desensitization of 2A receptors by DA and NE. A–D, Representative traces from MCH neurons showing
desensitizing response to repeated applications ofNE and/orDA.E,F, Summary ofDA (E) orNE (F ) currents followingapreviousDA
orNEapplication.G, Recovery rate ofDA currents fromdesensitization inducedbyDA. Secondpeak current amplitude is normalized
to the first one. H, I,2A receptors do not desensitize by short agonist applications. A 5 s NE application does not desensitize the
subsequent DA response (H ), and vice versa (I ). For both DA and NE, peak responses to 5 s or 5 min application are comparable.
Numbers in bar graphs denote the numbers of cells tested. For comparison, DA 100M and NE 100M data from Figures 1 and 2
are shown. *p 0.05, **p 0.01. ns, Not significant, ANOVA with Dunnett’s posttest.
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channels inMCHneurons (van den Pol et al., 2004; current study).
This is in contrast to what has been shown in normal rat kidney cell
line transfected with mouse 2ARs, in which DA and NE induce
opposite effects on cAMP accumulation (Zhang et al., 1999).
Our study suggests that EC50 of DA is approximately four
times higher than that of NE. This may reflect a difference in
affinity, asDAhas three to four times lower affinity to human and
mouse 2ARs than NE in expression systems (Zhang et al., 1999;
Nyro¨nen et al., 2001; Cornil and Ball, 2008). However, our cal-
culated EC50s may be overestimated, because the present study
used brain slices in which a combination of diffusion and re-
uptake can slow down the penetration of bath-applied DA and
NE (Nicholson, 1995). Local synaptic and extrasynaptic concen-
tration of endogenous DA in various brain regions has been esti-
mated to be within nanomolar (Ross, 1991; Kawagoe et al., 1992;
Garris et al., 1994) to millimolar range when the synaptic geom-
etry is taken into account (Garris et al., 1994). Moreover, using
ventral tegmental area slice preparations, DA concentration at
postsynaptic DA receptors has been estimated to be 	10 M
(Ford et al., 2009). Overall, our result showing that DA signifi-
cantly hyperpolarizes MCH neurons at 10 M suggest that the
cross talk of DA and 2AR is physiologically relevant for the
regulation of the MCH system.
Our study also demonstrated that, because NE and DA acti-
vate the same receptors and effector channels, functional cross-
desensitization occurs after long applications of either ligand.
This indicates that the history of either DA or NE activity could
affect the potency of subsequent NE or DA action, in particular
after prolonged release onto MCH neurons.
NE and DA are released in the LH in response to nutrient
intake (Myers and McCaleb, 1980; Meguid et al., 1995) and in-
jection of NE or DA into the same area reduces feeding (Mar-
gules, 1970; Leibowitz and Rossakis, 1978). While the exact
subtype of receptors responsible for the satiety effect of NE has
not been identified, it is likely that 2ARs expressed by MCH
neurons are involved. DA may also induce satiety through the
same pathway, although the anorexic effect of DA in the PFA/LH
can be reversed by a D2-like receptor antagonist (Leibowitz and
Rossakis, 1978). Therefore, other mechanisms may also be im-
portant, for example, DA- or NE-mediated inhibition of orexin
neurons (Li and van den Pol, 2005; Alberto et al., 2006), another
orexigenic cell type localized in the PFA/LH (Sakurai et al., 1998).
2ARs have been suggested to have anxiolytic and antide-
pressant properties, as 2AR knock-out mice display in-
creased anxiety- and depression-like behaviors (Schramm et
al., 2001; La¨hdesma¨ki et al., 2002). Although 2ARs are widely
expressed and have a wide spectrum of functions, the phenotype
seen in these animals may at least partially be explained by a lack
of suppression on the MCH system. This idea stems from the
anxiolytic and antidepressant effects demonstrated by MCH re-
ceptor antagonists (Borowsky et al., 2002; Georgescu et al., 2005).
DecreasingMCHrelease from these neurons by activating2ARs
can be expected to have an effect similar to that ofMCH receptor
antagonists. Furthermore, MCH has been shown to regulate the
DA function in the mesolimbic pathway (Smith et al., 2005),
which suggests, together with our findings, that DA is capable of
regulating its own activity/sensitivity indirectly by regulating
MCH neurons.
In summary, our study demonstrates a unique cross talk of
DA and NE at MCH neurons. DA binds directly to 2ARs and
activates GIRK channels as a partial agonist. SinceMCHneurons
are implicated in energy balance, reward, and anxiety, targeting
these receptors for mood disorders and obesity may be a viable
treatment option.
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